Dr. Yoshikazu Nakamura has served as RIBOMIC's President and CEO since 2012 when he retired from The University of Tokyo (currently Professor Emeritus). He founded the Company in 2003 when he was the UTokyo Professor at Institute of Medical Science. He has served the scientific community as the Vice President of A-IMBN since 2003, and the President of the RNA Society of Japan during 2006-2010. Throughout his academic career, Dr. Nakamura has been engaged in RNA science, and discovered a novel biological concept “molecular mimicry between protein and RNA” in 2000, which provided the basis of RIBOMIC’s R&D for aptamer therapeutics.